For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

In developing countries, there is a need for a simple but effective system to monitor the safety of medications during pregnancy. There are currently no established systems to monitor drug safety in pregnancy in malaria endemic countries. Stéphanie Dellicour develops and evaluates pharmacovigilance systems in resource constrained settings to provide a better estimate of the risk-benefit profile of artemisinin-based combination therapies (ACTs), which are now the recommended treatment for uncomplicated malaria.

Event details of Risks versus benefits of antimalaria drugs during pregnancy
Date 22 October 2014
Time 13:00 -14:00
Location Aula - Lutherse kerk

S.O.M.C. Dellicour, Assessment of Pharmacovigilance Approaches for Monitoring the Safety of Antimalarial Drugs in Pregnancy.

Supervisors

Prof. F.O. ter Kuile
Prof. M. Boele van Hensbroek

Co-supervisor

Dr M.R. Desai (Muljibhai Patel Urological Hospital, India)

Aula - Lutherse kerk

Singel 411
1012 XM Amsterdam

Entrance

This event is open to the public.